BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/7/2016 11:01:00 AM | Browse: 1671 | Download: 2305
Publication Name World Journal of Clinical Oncology
Manuscript ID 20597
Country France
ISSN 2218-4333 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Minireviews
Article Title Is breast conservative surgery a reasonable option in multifocal or multicentric tumors?
Manuscript Source Unsolicited Manuscript
All Author List Gilles Houvenaeghel, Agnès Tallet, Aurélie Jalaguier-Coudray, Monique Cohen, Marie Bannier, Camille Jauffret-Fara and Eric Lambaudie
Funding Agency and Grant Number
Corresponding Author Gilles Houvenaeghel, MD, Institut Paoli Calmettes and CRCM, Aix Marseille Université, 232 Bd de Sainte Marguerite, 13009 Marseille, France. houvenaeghelg@ipc.unicancer.fr
Key Words Mastectomy; Breast conservative surgery; Multifocal tumors; Multicentric tumors; Radiotherapy; Local recurrence; Breast cancer; Survival
Core Tip Multicentric and multifocal breast tumors should be identified preoperatively in order to adapt surgical treatment. They might be associated with more frequent lymph node involvement and worse prognosis but in most studies, the rates of local recurrence are low and similar to those of unifocal tumors. Breast conservative treatment is a reasonable option in selected patients (age 50-69 years, small tumors and absence of extensive ductal carcinoma in situ). Postoperative radiotherapy, and especially boost radiotherapy must be discussed and evaluated due to the risk of increased toxicity in case of double boost.
Publish Date 2016-04-07 11:01
Citation Houvenaeghel G, Tallet A, Jalaguier-Coudray A, Cohen M, Bannier M, Jauffret-Fara C, Lambaudie E. Is breast conservative surgery a reasonable option in multifocal or multicentric tumors? World J Clin Oncol 2016; 7(2): 234-242
URL http://www.wjgnet.com/2218-4333/full/v7/i2/234.htm
DOI http://dx.doi.org/10.5306/wjco.v7.i2.234
Full Article (PDF) WJCO-7-234.pdf
Full Article (Word) WJCO-7-234.doc